166 related articles for article (PubMed ID: 38105596)
21. Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1/2-Nrf2 signaling pathway.
Wang XL; Xing GH; Hong B; Li XM; Zou Y; Zhang XJ; Dong MX
Life Sci; 2014 Oct; 114(2):77-85. PubMed ID: 25132361
[TBL] [Abstract][Full Text] [Related]
22. Pinostrobin Exerts Neuroprotective Actions in Neurotoxin-Induced Parkinson's Disease Models through Nrf2 Induction.
Li C; Tang B; Feng Y; Tang F; Pui-Man Hoi M; Su Z; Ming-Yuen Lee S
J Agric Food Chem; 2018 Aug; 66(31):8307-8318. PubMed ID: 29961319
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rk1 protects human melanocytes from H
Xiong J; Yang J; Yan K; Guo J
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558653
[TBL] [Abstract][Full Text] [Related]
25. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
Zhao YF; Zhang Q; Xi JY; Li YH; Ma CG; Xiao BG
J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
27. The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2.
Campolo M; Casili G; Biundo F; Crupi R; Cordaro M; Cuzzocrea S; Esposito E
Antioxid Redox Signal; 2017 Sep; 27(8):453-471. PubMed ID: 28006954
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
Yang W; Chen YH; Liu H; Qu HD
Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
[TBL] [Abstract][Full Text] [Related]
29. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
Xu X; Song N; Wang R; Jiang H; Xie J
Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
[TBL] [Abstract][Full Text] [Related]
30. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease.
Zhou TT; Zu G; Wang X; Zhang XG; Li S; Liang ZH; Zhao J
Int Immunopharmacol; 2015 Dec; 29(2):334-343. PubMed ID: 26548343
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
[TBL] [Abstract][Full Text] [Related]
33. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.
Fujita A; Fujita Y; Pu Y; Chang L; Hashimoto K
Psychopharmacology (Berl); 2020 Jan; 237(1):83-92. PubMed ID: 31418048
[TBL] [Abstract][Full Text] [Related]
34. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Nrf2-dependent mechanism of b-Ecdysterone in attenuating the motor dysfunction in the MPTP/Pro-induced Parkinson's disease mice model.
Rong H; Li X; Yu C; Wang W; Li L; Xu T; Ding Y; Su Y; Wang X
Folia Neuropathol; 2024; 62(1):83-95. PubMed ID: 38174686
[TBL] [Abstract][Full Text] [Related]
36. Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease.
Lv E; Deng J; Yu Y; Wang Y; Gong X; Jia J; Wang X
Free Radic Res; 2015; 49(11):1296-307. PubMed ID: 26118717
[TBL] [Abstract][Full Text] [Related]
37. Baicalein protects against MPP
Song Q; Peng S; Zhu X
Neurotoxicology; 2021 Dec; 87():188-194. PubMed ID: 34666128
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
39. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
Geng L; Zhang T; Liu W; Chen Y
Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
[TBL] [Abstract][Full Text] [Related]
40. Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.
Ma X; Cao F; Cui J; Li X; Yin Z; Wu Y; Wang Q
Mol Biol Rep; 2024 May; 51(1):669. PubMed ID: 38787465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]